▲ Peaking
Business
New Drugs Are Replacing Chemo for Aggressive Breast Cancer
The FDA has granted broad first-line approval for Gilead's Trodelvy, signaling a shift away from traditional chemotherapy for aggressive breast cancer.
Fda
3 trends tracked about this subject — the full history, oldest to newest below.
▲ Peaking
Health
🔮 holds
The Wearable Data Your Doctor Actually Wants
Wearable technology is shifting from general fitness tracking toward clinical healthcare integration and Medicare eligibility.
◼ Archived
Business
🔮 holds ✗
HHS Launches Unprecedented Department-Wide Effort to Restore American Leadership in Clinical Trials
The U.S. Department of Health and Human Services is launching a department-wide effort to accelerate clinical trials and restore American leadership in medical research.